搜索
Abcellera Biologics Inc
ABCL添加自选
12.310USD
-0.340-2.69%
收盘 09-23 16:00（美东）
3.76B总市值
亏损市盈率 TTM
盘后交易 17:00 (美东)12.340USD+0.025+0.20%Abcellera Biologics Inc
12.310
-0.340-2.69%
ABCL 现金流量表
您可以访问Abcellera Biologics Inc的年度和季度现金流量表，以评估其财务稳健性和稳定性。
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2019Q4
经营活动现金流量（间接法）
持续经营活动现金净额
180.00%25.92M
-190.14%-33.52M
-334.29%-34.74M
-82.10%-52.59M
-8.14%-32.40M
72.30%-11.55M
59.21%-8.00M
-27147.17%-28.88M
-250.56%-29.97M
5.34%-41.71M
-163.44%-19.61M
99.92%-106.00K
-92.71%19.90M
-143.97%-44.06M
284.97%30.91M
-2037.32%-126.79M
73.14%273.01M
-8.51%100.22M
-1409.32%-16.71M
---5.93M
--157.68M
--109.55M
177.91%1.28M
--459.28K
持续经营净收入
-59.61%-55.43M
5.38%-43.16M
73.85%-8.95M
-11.76%-57.12M
5.97%-34.73M
-12.34%-45.62M
27.44%-34.21M
-78.63%-51.11M
-20.97%-36.93M
-1.25%-40.61M
-57.73%-47.15M
-207.46%-28.61M
-349.93%-30.53M
-123.79%-40.11M
-149.86%-29.89M
224.52%26.62M
-192.08%-6.79M
43.81%168.57M
-48.76%59.95M
---21.38M
---2.32M
--117.22M
7229.88%117.00M
---1.64M
持续经营损益
27.76%6.99M
3.53%6.84M
-51.27%6.12M
-85.79%5.25M
-85.02%5.47M
36.35%6.61M
66.72%12.56M
543.75%36.92M
551.02%36.52M
-12.15%4.84M
-45.34%7.54M
11.10%5.74M
14.56%5.61M
37.95%5.51M
247.02%13.79M
40.85%5.16M
39.04%4.90M
20.94%4.00M
58.46%3.97M
--3.67M
--3.52M
--3.31M
491.11%2.51M
--424.17K
递延税费
----
----
----
----
----
----
----
----
----
----
192.72%1.96M
----
----
----
-269.26%-2.11M
----
----
----
-40.47%1.25M
---4.02M
--133.00K
--623.00K
--2.10M
----
其他非现金项目
598.45%6.43M
89.52%4.19M
-424.32%-2.52M
143.80%3.65M
84.60%-1.29M
-39.02%2.21M
-358.60%-481.00K
-3215.54%-8.32M
-1085.31%-8.38M
278.94%3.63M
-97.27%186.00K
-104.86%-251.00K
-40.82%851.00K
-628.13%-2.03M
90.82%6.82M
179.65%5.17M
209.25%1.44M
-18.30%384.00K
-10.19%3.57M
--1.85M
--465.00K
--470.00K
5336.56%3.98M
--73.16K
营运资金变化
431.16%55.64M
-228.10%-13.40M
-410.17%-46.22M
-216.58%-18.14M
-109.10%-16.80M
138.78%10.46M
957.56%14.90M
-180.04%-5.73M
-129.14%-8.04M
-17.75%-26.98M
-95.14%1.41M
104.08%7.16M
-89.45%27.57M
73.05%-22.91M
130.68%28.99M
-2907.01%-175.49M
77.29%261.35M
-385.84%-85.03M
26.93%-94.49M
--6.25M
--147.41M
---17.50M
-13133.16%-129.32M
--992.22K
-应收款项（增）减
207.66%12.26M
1256.49%13.10M
-90.14%-39.67M
82.68%-3.43M
28.17%-11.39M
93.90%-1.13M
-99.86%-20.86M
-76.79%-19.82M
50.73%-15.86M
-208.16%-18.58M
-115.78%-10.44M
81.10%-11.21M
-111.65%-32.18M
109.72%17.18M
148.11%66.17M
-481.07%-59.33M
87.13%276.29M
-5400.16%-176.66M
31.05%-137.52M
--15.57M
--147.64M
---3.21M
-26331.98%-199.45M
--760.34K
-应付款项及应计费用（减）增
-82.80%-7.21M
-175.92%-9.41M
-13.21%5.74M
22.23%5.07M
-183.13%-3.95M
30.11%-3.41M
149.93%6.62M
325.44%4.15M
60.89%4.75M
15.58%-4.88M
-697.74%-13.25M
33.38%975.00K
212.08%2.95M
-869.37%-5.78M
29.42%2.22M
-78.03%731.00K
-269.43%-2.63M
114.46%751.00K
-74.05%1.71M
--3.33M
--1.55M
---5.19M
4297.88%6.60M
--150.09K
-其他流动资产变化
-41.62%3.58M
-123.78%-1.74M
-37.93%3.07M
-74.69%628.00K
187.52%6.13M
303.05%7.32M
6.11%4.95M
-72.89%2.48M
73.33%2.13M
40.54%-3.60M
280.18%4.66M
214.18%9.15M
-64.01%1.23M
19.77%-6.06M
-64.55%1.23M
874.25%2.91M
190.98%3.42M
---7.56M
--3.46M
--299.00K
---3.76M
----
----
----
-其他流动负债变化
1234.49%50.06M
-185.91%-10.39M
-160.13%-5.32M
-180.20%-8.20M
-218.82%-4.41M
270.84%12.09M
-52.63%8.84M
318.42%10.22M
-81.50%3.71M
120.86%3.26M
29.26%18.66M
107.49%2.44M
905.81%20.08M
-154.89%-15.63M
-41.98%14.44M
-137.32%-32.62M
-91.89%2.00M
2817.56%28.48M
13.44%24.88M
---13.75M
--24.62M
---1.05M
2272.44%21.93M
--924.36K
非持续经营活动现金净额
经营活动现金净额
180.00%25.92M
-190.14%-33.52M
-334.29%-34.74M
-82.10%-52.59M
-8.14%-32.40M
72.30%-11.55M
59.21%-8.00M
-27147.17%-28.88M
-250.56%-29.97M
5.34%-41.71M
-163.44%-19.61M
99.92%-106.00K
-92.71%19.90M
-143.97%-44.06M
284.97%30.91M
-2037.32%-126.79M
73.14%273.01M
-8.51%100.22M
-1409.32%-16.71M
---5.93M
--157.68M
--109.55M
177.91%1.28M
--459.28K
投资活动现金流量
持续投资活动现金净额
-84.05%2.13M
-63.98%3.83M
-37.02%9.84M
-51.78%8.93M
-33.54%13.37M
-55.94%10.64M
8.31%15.63M
-11.37%18.52M
-26.07%20.11M
61.11%24.14M
17.04%14.43M
43.95%20.89M
-13.16%27.20M
3.37%14.98M
30.75%12.33M
69.27%14.51M
-14.90%31.32M
297.78%14.49M
527.78%9.43M
--8.57M
--36.80M
--3.64M
157.58%1.50M
--583.16K
资本性支出
-84.05%2.13M
-63.98%3.83M
-37.02%9.84M
-51.78%8.93M
-33.54%13.37M
-55.94%10.64M
8.31%15.63M
-11.37%18.52M
-26.07%20.11M
61.11%24.14M
17.04%14.43M
43.95%20.89M
-13.16%27.20M
3.37%14.98M
30.75%12.33M
69.27%14.51M
-14.90%31.32M
297.78%14.49M
527.78%9.43M
--8.57M
--36.80M
--3.64M
157.58%1.50M
--583.16K
固定资产交易的净现金流
-84.05%2.13M
-63.98%3.83M
-37.02%9.84M
-51.78%8.93M
-33.54%13.37M
-55.94%10.64M
8.31%15.63M
-8.93%18.52M
-26.07%20.11M
61.11%24.14M
17.04%14.43M
62.48%20.33M
-13.16%27.20M
3.37%14.98M
30.75%12.33M
45.94%12.51M
-14.90%31.32M
297.78%14.49M
527.78%9.43M
--8.57M
--36.80M
--3.64M
157.58%1.50M
--583.16K
无形资产交易净现金流
----
----
----
----
----
----
----
----
----
----
--0.00
-72.00%560.00K
----
----
--0.00
--2.00M
----
----
--0.00
--0.00
--0.00
--0.00
----
----
业务交易的净现金流
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
--0.00
----
----
----
100.00%0.00
---11.46M
----
----
---87.64M
----
投资产品交易的净现金流
136.95%7.88M
-216.34%-22.61M
-83.05%7.87M
135.33%46.95M
-133.04%-21.32M
-63.18%19.44M
378.05%46.45M
362.23%19.95M
746.36%64.54M
139.74%52.79M
-1342.49%-16.70M
101.60%4.32M
-266.92%-9.98M
-2064.72%-132.85M
89.77%-1.16M
-8.51%-269.41M
218.83%5.98M
---6.14M
---11.31M
---248.29M
---5.03M
----
----
----
其他投资活动的净现金流
3.02%5.59M
33.69%1.36M
1079.60%77.36M
-90.23%918.00K
-56.84%5.43M
-85.80%1.02M
-36.26%6.56M
28.24%9.40M
151.64%12.58M
166.17%7.17M
340.79%10.29M
22.13%7.33M
-9.12%5.00M
3.74%2.69M
-89.77%2.33M
13.52%6.00M
21.73%5.50M
--2.60M
10771.26%22.81M
--5.29M
--4.52M
----
567.67%209.86K
---44.87K
非持续投资活动现金净额
投资活动现金净额
135.65%11.34M
-416.08%-25.08M
110.45%75.14M
886.70%36.49M
-161.06%-31.81M
-73.47%7.94M
246.79%35.70M
128.92%3.70M
251.49%52.10M
119.99%29.91M
-42.55%-24.32M
95.47%-12.79M
-26.45%-34.39M
-467.32%-149.61M
-1385.03%-17.06M
-4.59%-281.99M
40.40%-27.20M
-66.49%-26.37M
98.94%-1.15M
---269.63M
---45.63M
---15.84M
-17125.57%-108.18M
---628.03K
融资活动现金流量
持续融资活动现金净额
289.42%6.39M
20.47%7.19M
-0.65%4.12M
134.40%7.37M
-227.31%-3.38M
110.88%5.97M
10.01%4.14M
-52.56%3.15M
532.70%2.65M
718.12%2.83M
978.80%3.77M
34994.74%6.63M
-64.28%419.00K
85.37%-458.00K
-80.97%349.00K
-102.12%-19.00K
123.11%1.17M
-102.92%-3.13M
-99.70%1.83M
--898.00K
---5.08M
---1.54M
245551.35%609.94M
--248.29K
债务发行/偿还的净现金流
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
---250.00K
-100.13%-1.00K
95.80%-72.00K
-100.00%0.00
--0.00
--765.00K
---1.72M
34551.58%86.99M
--251.05K
普通股发行/偿还的净现金流
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--522.84M
----
优先股发行/偿还的净现金流
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
100.00%0.00
--0.00
--0.00
--0.00
94.69%-592.00
---11.15K
职工行使股票期权收到的现金
-230.64%-7.19M
16.98%7.19M
-11.70%10.52M
3227.75%7.55M
1094.14%5.50M
589.24%6.15M
201.72%11.92M
-96.76%227.00K
211.49%461.00K
82.04%892.00K
1031.81%3.95M
2931.17%7.00M
-36.75%148.00K
-74.76%490.00K
-80.97%349.00K
-74.28%231.00K
-86.32%234.00K
1021.97%1.94M
1611.64%1.83M
--898.00K
--1.71M
--173.00K
1175.89%107.15K
--8.40K
其他融资活动的净现金流额
252.98%13.59M
100.00%0.00
17.58%-6.41M
-106.24%-182.00K
-505.48%-8.88M
-109.18%-178.00K
-4103.24%-7.78M
884.41%2.92M
708.12%2.19M
304.54%1.94M
---185.00K
---372.00K
-71.17%271.00K
81.04%-948.00K
--0.00
--0.00
112.45%940.00K
---5.00M
--0.00
--0.00
---7.55M
--0.00
----
---1.00
非持续融资活动现金净额
融资活动现金净额
289.42%6.39M
20.47%7.19M
-0.65%4.12M
134.40%7.37M
-227.31%-3.38M
110.88%5.97M
10.01%4.14M
-52.56%3.15M
532.70%2.65M
718.12%2.83M
978.80%3.77M
34994.74%6.63M
-64.28%419.00K
85.37%-458.00K
-80.97%349.00K
-102.12%-19.00K
123.11%1.17M
-102.92%-3.13M
-99.70%1.83M
--898.00K
---5.08M
---1.54M
245551.35%609.94M
--248.29K
现金净流量
期初现金流
-44.36%103.80M
-15.45%155.25M
-28.25%110.45M
-31.82%119.73M
23.66%186.56M
14.32%183.62M
-22.92%153.93M
-15.18%175.60M
-31.52%150.86M
-61.27%160.61M
-50.08%199.71M
-74.67%207.04M
-61.46%220.31M
-17.26%414.65M
-22.72%400.09M
3.14%817.44M
-16.64%571.65M
-15.65%501.14M
468.38%517.69M
--792.57M
--685.79M
--594.12M
1118.75%91.08M
--7.47M
当期现金流变化
164.68%43.23M
-1849.40%-51.45M
50.92%44.80M
57.19%-9.28M
-370.13%-66.83M
130.17%2.94M
175.92%29.68M
-195.86%-21.67M
286.42%24.74M
94.98%-9.75M
-368.51%-39.10M
98.24%-7.33M
-105.40%-13.27M
-375.61%-194.34M
187.98%14.56M
-51.83%-417.35M
130.19%245.78M
-23.09%70.51M
-103.29%-16.55M
---274.88M
--106.78M
--91.68M
632345.06%503.03M
--79.54K
利率变动影响
-156.50%-430.00K
-106.44%-38.00K
113.43%290.00K
-248.23%-544.00K
1869.77%761.00K
175.54%590.00K
-302.25%-2.16M
134.52%367.00K
-105.40%-43.00K
-266.67%-781.00K
193.41%1.07M
87.57%-1.06M
166.03%797.00K
-4.41%-213.00K
169.33%364.00K
-3841.01%-8.55M
-506.53%-1.21M
57.85%-204.00K
---525.00K
---217.00K
---199.00K
---484.00K
----
----
期末现金流
22.80%147.03M
-44.36%103.80M
-15.45%155.25M
-28.25%110.45M
-31.82%119.73M
23.66%186.56M
14.32%183.62M
-22.92%153.93M
-15.18%175.60M
-31.52%150.86M
-61.27%160.61M
-50.08%199.71M
-74.67%207.04M
-61.46%220.31M
-17.26%414.65M
-22.72%400.09M
3.14%817.44M
-16.64%571.65M
-15.65%501.14M
--517.69M
--792.57M
--685.79M
7766.05%594.12M
--7.55M
自由现金流
151.98%23.79M
-68.34%-37.35M
-88.68%-44.59M
-29.80%-61.52M
8.60%-45.77M
66.30%-22.19M
30.59%-23.63M
-125.74%-47.40M
-586.16%-50.08M
-11.52%-65.85M
-283.20%-34.04M
85.14%-21.00M
-103.02%-7.30M
-168.88%-59.05M
171.08%18.58M
-874.07%-141.30M
99.95%241.69M
-19.05%85.72M
-11480.84%-26.14M
---14.51M
--120.88M
--105.90M
-82.21%-225.74K
---123.88K
货币单位
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
审计意见
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
常见问题
什么是经营活动现金流？
经营活动现金流是公司核心业务产生或使用的现金。它以净利润为基础，并对折旧等非现金项目以及应收账款、存货和应付账款等营运资金变动进行调整。强劲的经营活动现金流通常表明，公司能够将销售收入和利润有效转化为实际现金。
Abcellera Biologics Inc 产生了多少经营活动现金流？
Abcellera Biologics Inc 2025 财年的经营活动现金流为 -131.29M，反映其核心业务经营活动产生的现金。
Abcellera Biologics Inc 的经营活动现金流同比有何变化？
Abcellera Biologics Inc 的经营活动现金流同比增长 -20.95%。
什么是投资活动现金流？
投资活动现金流反映公司投资相关活动所使用或产生的现金，例如资本支出、投资买卖、企业收购和资产处置。投资活动现金流为负并不一定是坏事，因为这可能意味着公司正在为未来增长进行投入。不过，投资者仍需判断这些投资能否带来长期回报。
Abcellera Biologics Inc 的资本支出是多少？
Abcellera Biologics Inc 最近一个季度的资本支出为 42.77M。
什么是融资活动现金流？
融资活动现金流反映公司如何筹集资金，或向投资者和债权人返还资金，包括发行和偿还债务、发行和回购股份、支付股息以及租赁融资等。融资活动现金流为正，可能表示公司筹集了新资金；为负则可能反映公司正在偿还债务、派发股息或回购股份。
Abcellera Biologics Inc 的融资活动现金流有何变化？
Abcellera Biologics Inc 最近一个季度用于融资活动的现金为 14.08M。
什么是自由现金流？它对 ABCL 有何重要意义？
自由现金流是公司在支付维持或拓展业务所需的资本支出后剩余的现金。它通常用于评估公司的财务灵活性、偿债能力、股息可持续性、股份回购能力和估值水平。投资者还应将自由现金流与净利润、营收增长和资本支出结合分析。
Abcellera Biologics Inc 最近一个季度的自由现金流是多少？
Abcellera Biologics Inc 最近一个季度的自由现金流为 -174.07M，较上年同期变动 6.89%。